chivato-t 1

1. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
2. Management of anaphylaxis due to COVID-19 vaccines in the elderly
3. Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force Report
4. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
5. Allergen immunotherapy in MASK-air users in real-life: Results of a Bayesian mixed-effects model
6. Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air^® real-world data
7. Comparison of rhinitis treatments using MASK-air® data and considering the minimal important difference
8. Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal study
1